Mayukh Sukhatme

Mayukh Sukhatme

President at ROIVANT SCIENCES LTD.

Net worth: 56 M $ as of 30/03/2024

48 year
Finance
Health Technology
Consumer Services

Profile

Currently, Mayukh Sukhatme holds the position of Co-President & Chief Investment Officer at Roivant Sciences Ltd., Co-President & Chief Investment Officer at Roivant Sciences GmbH (a subsidiary of Roivant Sciences Ltd.) and Co-President & Chief Investment Officer at Montes Archimedes Acquisition Corp. In his past career Dr. Sukhatme held the position of Principal at Hutchin Hill Capital LP, Partner at Apple Tree Partners, Portfolio Manager at Sio Capital Management LLC and Chairman for Urovant Sciences Ltd. Dr. Sukhatme received an undergraduate degree from Massachusetts Institute of Technology and a doctorate from Harvard Medical School.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
29/03/2024 5,309,683 ( 0.66% ) 56 M $ 30/03/2024

Mayukh Sukhatme active positions

CompaniesPositionStart
ROIVANT SCIENCES LTD. President 31/12/2020
President 31/12/2014
All active positions of Mayukh Sukhatme

Former positions of Mayukh Sukhatme

CompaniesPositionEnd
AVALO THERAPEUTICS, INC. Director/Board Member 11/08/2015
ROIVANT SCIENCES LTD. President -
UROVANT SCIENCES LTD. Chairman -
Private Equity Investor -
Corporate Officer/Principal -
See the detail of Mayukh Sukhatme's experience

Training of Mayukh Sukhatme

Massachusetts Institute of Technology Undergraduate Degree
Harvard Medical School Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mayukh Sukhatme's experience

Connections

100 +

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
ROIVANT SCIENCES LTD.

Health Technology

AVALO THERAPEUTICS, INC.

Health Technology

Private companies6

Finance

Finance

Finance

Health Technology

Health Technology

Finance

See company connections
  1. Stock Market
  2. Insiders
  3. Mayukh Sukhatme